Swedish life science
Sciety selects investments in biotechnology, digital health, ICT in healthcare, pharmaceuticals and medical technology.
The companies are in various development phases depending on the sector and innovation level. Pharmaceutical companies are often in an early clinical phase while, for example, health tech companies must have reached an initial user base.
Sciety focuses on Swedish companies with the goal to be acquired or listed within three years. The companies’ capital requirements are between MSEK 10 and MSEK 100.
The companies presented have been subjected to our extensive selection and review process where, among other things, business potential, medical relevance and legal documents are reviewed.
We have extensive experience in the industry and cooperates with research parks, healthcare providers and industry organizations.
Sciety works actively to identify and select prominent companies and knows the majority of Swedish companies in life science. Company information is stored in our database, which facilitates structured work with analysis and selection.
Industry players, venture capital companies and experienced private investors with an interest in life science invest through Sciety. As a member it is at your discretion to decide which companies you wish to invest in. You become a direct shareholder, which enables investor deductions, among other things.
Our online investment portal allows you to easily access all the details and make your investments.
Sciety ensures the quality of the investment process and handles the settlement notes, client funds and reconciliations.
As a members of the Sciety investment syndicate you receive exclusive invitations to presentations with the companies' management and priority over information on new investment opportunities.
Sciety membership is free. In the application process, we always perform an identity check and ask the new member to fill out a questionnaire, in order to offer a secure service and comply with financial regulation.
Venture capital companies and funds, financial intermediaries along with governmental and industrial players co-invest with Sciety, relying on our far-reaching life science and health care expertise.
Do you want to discuss a specific investment or establish a long-term cooperation? Contact us for more information.